צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: Collegium Corp (COLL)

Collegium Pharmaceutical specializes in chronic pain therapy, leveraging stable benefits from the patent protection of its formulas. The use of unique opioid abuse-deterrent technologies transforms its asset portfolio into a reliable profit generator. Business success relies on the sales of non-opioid agents and strict compliance with regulatory standards. The GURU.Markets terminal displays a chart of the TTM revenue growth YoY, where the value of the indicator is 7.50.
collegiumpharma.com - פילוחים אנליטיים ומדדי מפתח (COLL)

Professional investors select resilient assets by analyzing long-term patterns while filtering out short-term market noise. The TTM revenue growth rate compared to the previous year measures the percentage change in sales over a rolling 12-month period, confirming the stability of cash flows for Collegium Pharmaceutical (COLL) due to the maturity of its analgesic product line and the high demand for chronic pain medications.